RIPK1 and hepatocellular carcinoma: Mice with liver parenchymal cell (LPC)-specific NEMO deficiency (NEMOLPC-KO) spontaneously develop steatohepatitis and hepatocellular carcinoma (HCC), which is driven by RIPK1 kinase-dependent hepatocyte apoptosis14,48,49.